Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
A definitive Cruiser Standoff: Decision in favor of Your #1 Ride- Satellite observations offer insight into a tsunami's early stages
- Study reveals how fast weight returns after ending GLP-1 drugs
- Manual for Conservative SUVs For Seniors
- US students studying housing, health outcomes and sustainability win 2026 Rhodes scholarships
- IDF begins destroying homes used by Hezbollah as forces move deeper into southern Lebanon
- Tickets for 'Stranger Things' Season 5 finale, to be shown in movie theaters on New Year's Eve, go on sale today. Here's how you can save your seat.
- Figure out How to Protect Your Gold Venture from Unpredictability
- A photographer finds thousands of dinosaur footprints near Italian Winter Olympic venue
